Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Seibold

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Arthritis and Rheumatism|November 1, 1982
Digital sclerosis in children with insulin-dependent diabetes mellitusJ R Seibold
Current Opinion in Rheumatology|November 8, 2001
Clinical trials: types, design, and end-pointsJ R Seibold
Annals of the Rheumatic Diseases|May 1, 1994
Critical tissue ischaemia in scleroderma: a note of cautionJ R Seibold
Journal of Cardiovascular Pharmacology|January 1, 1985
Serotonin and Raynaud's phenomenonJ R Seibold
JAMA|May 8, 1981
Osteonecrosis vs transient osteoporosisM Rosen, J R Seibold
Angiology|June 1, 1990
Cyanosis and Raynaud's phenomenon: the relation to underlying disease and venous abnormalitiesM Engelhart, J R Seibold
Angiology|September 1, 1990
The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenonM Engelhart, J R Seibold
The American Journal of Gastroenterology|April 1, 1992
Mesenteric thrombosis associated with anticardiolipin antibodies in a patient with systemic lupus erythematosusM S Cappell, J R Seibold
Current Opinion in Rheumatology|November 13, 1998
Rational use of calcium-channel antagonists in Raynaud's phenomenonM G Sturgill, J R Seibold
Clinics in Dermatology|April 1, 1994
The treatment of Raynaud's phenomenonJ R Seibold, N E Allegar
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Arthritis and Rheumatism|November 1, 1982
Digital sclerosis in children with insulin-dependent diabetes mellitusJ R Seibold
Current Opinion in Rheumatology|November 8, 2001
Clinical trials: types, design, and end-pointsJ R Seibold
Annals of the Rheumatic Diseases|May 1, 1994
Critical tissue ischaemia in scleroderma: a note of cautionJ R Seibold
Journal of Cardiovascular Pharmacology|January 1, 1985
Serotonin and Raynaud's phenomenonJ R Seibold
JAMA|May 8, 1981
Osteonecrosis vs transient osteoporosisM Rosen, J R Seibold
Angiology|June 1, 1990
Cyanosis and Raynaud's phenomenon: the relation to underlying disease and venous abnormalitiesM Engelhart, J R Seibold
Angiology|September 1, 1990
The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenonM Engelhart, J R Seibold
The American Journal of Gastroenterology|April 1, 1992
Mesenteric thrombosis associated with anticardiolipin antibodies in a patient with systemic lupus erythematosusM S Cappell, J R Seibold
Current Opinion in Rheumatology|November 13, 1998
Rational use of calcium-channel antagonists in Raynaud's phenomenonM G Sturgill, J R Seibold
Clinics in Dermatology|April 1, 1994
The treatment of Raynaud's phenomenonJ R Seibold, N E Allegar
Pageof 11